Piper Sandler Cuts Globus Medical (NYSE:GMED) Price Target to $80.00
Globus Medical (NYSE:GMED – Free Report) had its target price reduced by Piper Sandler from $100.00 to $80.00 in a report issued on Friday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the medical device company’s stock. Several other equities analysts have also recently weighed in on GMED. Wells Fargo & Company decreased […]
Globus Medical (NYSE:GMED – Free Report) had its target price reduced by Piper Sandler from $100.00 to $80.00 in a report issued on Friday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the medical device company’s stock. Several other equities analysts have also recently weighed in on GMED. Wells Fargo & Company decreased […]
